MedTrace Logo

REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry

NCT06354777 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 312

Last updated 2025-10-31

No results posted yet for this study

Summary

This is a multi-center sub-study examining the effectiveness of active esophageal cooling on subjects undergoing left atrial ablation for symptomatic Paroxysmal Atrial Fibrillation or Persistent Atrial Fibrillation.

Conditions

Interventions

DEVICE

Atrial Ablation

Left atrial radiofrequency ablation for the treatment of atrial fibrillation; this may include Pulmonary Vein Isolation (PVI) with or without additional ablation lesions as warranted during the procedure

Sponsors & Collaborators

  • Attune Medical

    collaborator OTHER

  • Heart Rhythm Clinical and Research Solutions, LLC

    lead OTHER

Principal Investigators

  • Tiffany Sharkoski, MPH · Haemonetics Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-03
Primary Completion
2026-04-30
Completion
2026-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06354777 on ClinicalTrials.gov